ES2262308T3 - Ensayos de sensibilidad a antibioticos. - Google Patents
Ensayos de sensibilidad a antibioticos.Info
- Publication number
- ES2262308T3 ES2262308T3 ES99901020T ES99901020T ES2262308T3 ES 2262308 T3 ES2262308 T3 ES 2262308T3 ES 99901020 T ES99901020 T ES 99901020T ES 99901020 T ES99901020 T ES 99901020T ES 2262308 T3 ES2262308 T3 ES 2262308T3
- Authority
- ES
- Spain
- Prior art keywords
- bacteria
- culture
- antibiotic
- adenylate kinase
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003115 biocidal effect Effects 0.000 title claims description 66
- 238000012360 testing method Methods 0.000 title claims description 43
- 230000035945 sensitivity Effects 0.000 title claims description 25
- 102000002281 Adenylate kinase Human genes 0.000 claims abstract description 80
- 108020000543 Adenylate kinase Proteins 0.000 claims abstract description 80
- 230000001580 bacterial effect Effects 0.000 claims abstract description 29
- 230000012010 growth Effects 0.000 claims abstract description 28
- 230000000694 effects Effects 0.000 claims abstract description 19
- 238000003556 assay Methods 0.000 claims abstract description 14
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims abstract description 12
- 108091000080 Phosphotransferase Proteins 0.000 claims abstract description 10
- 238000004113 cell culture Methods 0.000 claims abstract description 10
- 238000000021 kinase assay Methods 0.000 claims abstract description 10
- 102000020233 phosphotransferase Human genes 0.000 claims abstract description 10
- 230000003834 intracellular effect Effects 0.000 claims abstract description 8
- 238000000099 in vitro assay Methods 0.000 claims abstract description 3
- 241000894006 Bacteria Species 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 60
- 230000009089 cytolysis Effects 0.000 claims description 34
- 239000003242 anti bacterial agent Substances 0.000 claims description 33
- 239000003795 chemical substances by application Substances 0.000 claims description 33
- 230000002101 lytic effect Effects 0.000 claims description 29
- 239000003153 chemical reaction reagent Substances 0.000 claims description 27
- 241001515965 unidentified phage Species 0.000 claims description 27
- 229940088710 antibiotic agent Drugs 0.000 claims description 26
- 230000002599 biostatic effect Effects 0.000 claims description 18
- 238000003312 immunocapture Methods 0.000 claims description 13
- 239000001963 growth medium Substances 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 claims description 4
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 claims description 4
- 230000005526 G1 to G0 transition Effects 0.000 claims description 4
- 108060001084 Luciferase Proteins 0.000 claims description 4
- 239000005089 Luciferase Substances 0.000 claims description 4
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 238000003149 assay kit Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims 2
- 239000013043 chemical agent Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 45
- 241000588724 Escherichia coli Species 0.000 description 16
- 229960000723 ampicillin Drugs 0.000 description 13
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 13
- 229960005091 chloramphenicol Drugs 0.000 description 13
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 9
- 238000011534 incubation Methods 0.000 description 7
- 239000011324 bead Substances 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000006037 cell lysis Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 238000002829 antibacterial sensitivity test Methods 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000017066 negative regulation of growth Effects 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- -1 penicillins Chemical class 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9801126 | 1998-01-21 | ||
| GBGB9801126.5A GB9801126D0 (en) | 1998-01-21 | 1998-01-21 | Antibiotic sensitivity testing |
| GBGB9816993.1A GB9816993D0 (en) | 1998-01-21 | 1998-08-06 | Antibiotic sensitivity testing |
| GB9816993 | 1998-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2262308T3 true ES2262308T3 (es) | 2006-11-16 |
Family
ID=26312981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99901020T Expired - Lifetime ES2262308T3 (es) | 1998-01-21 | 1999-01-12 | Ensayos de sensibilidad a antibioticos. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6861230B1 (enExample) |
| EP (1) | EP1049798B1 (enExample) |
| JP (1) | JP2002500892A (enExample) |
| CN (1) | CN1152963C (enExample) |
| AT (1) | ATE330025T1 (enExample) |
| AU (1) | AU751388C (enExample) |
| BR (1) | BR9907161A (enExample) |
| CA (1) | CA2318367C (enExample) |
| DE (1) | DE69931892T2 (enExample) |
| DK (1) | DK1049798T3 (enExample) |
| ES (1) | ES2262308T3 (enExample) |
| GB (1) | GB2348702B (enExample) |
| HU (1) | HUP0101276A3 (enExample) |
| NO (1) | NO20003708L (enExample) |
| NZ (1) | NZ505847A (enExample) |
| WO (1) | WO1999037799A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9911095D0 (en) | 1999-05-13 | 1999-07-14 | Secr Defence | Microbiological test method and reagents |
| GB0030727D0 (en) | 2000-12-15 | 2001-01-31 | Lumitech Uk Ltd | Methods and kits for detecting kinase activity |
| GB0122790D0 (en) * | 2001-09-21 | 2001-11-14 | Secr Defence | Method of determining the presence of target bacteria |
| GB0308199D0 (en) * | 2003-04-09 | 2003-05-14 | Acolyte Biomedica Ltd | Combined microbiology system |
| GB2400659B8 (en) | 2003-04-17 | 2007-07-09 | Cambrex Bio Science Nottingham | Assay methods and materials |
| WO2005027714A2 (en) | 2003-07-12 | 2005-03-31 | Accelr8 Technology Corporation | Sensitive and rapid biodetection |
| US20120077206A1 (en) | 2003-07-12 | 2012-03-29 | Accelr8 Technology Corporation | Rapid Microbial Detection and Antimicrobial Susceptibility Testing |
| AU2004258731B2 (en) | 2003-07-23 | 2010-02-25 | Biocontrol Limited | Bacteriophage-containing therapeutic agents |
| GB0324650D0 (en) * | 2003-10-22 | 2003-11-26 | Acolyte Biomedica Ltd | Using nucleic acids for clinical microbiology testing |
| WO2006005190A1 (en) * | 2004-07-14 | 2006-01-19 | Inimex Pharmaceuticals Inc. | Method of screening for protection from microbial infection |
| CA2586299C (en) * | 2004-11-01 | 2014-10-28 | James W. Stave | Method for detecting or enriching a target microorganism upon lysis of non-target bacteria with bacteriophage |
| WO2006066216A2 (en) * | 2004-12-16 | 2006-06-22 | Accelr8 Technology Corporation | Rapid microbial detection and antimicrobial susceptibility testing |
| GB2432660A (en) | 2005-11-29 | 2007-05-30 | Bacterioscan Ltd | System for counting bacteria and determining their susceptibility to antibiotics |
| US20080220465A1 (en) * | 2007-03-05 | 2008-09-11 | Pocared Diagnostics, Inc. | Antibiotic Sensitivity Testing Method |
| GB0704553D0 (en) * | 2007-03-09 | 2007-04-18 | Harper David R | Beneficial effects of bacteriophage treatments |
| CA2690809A1 (en) * | 2007-06-15 | 2008-12-24 | Microphage Incorporated | Method of detection of microorganisms with enhanced bacteriophage amplification |
| US9005579B2 (en) | 2010-01-05 | 2015-04-14 | Contrafect Corporation | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
| US10254204B2 (en) | 2011-03-07 | 2019-04-09 | Accelerate Diagnostics, Inc. | Membrane-assisted purification |
| US9434937B2 (en) | 2011-03-07 | 2016-09-06 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
| US9677109B2 (en) | 2013-03-15 | 2017-06-13 | Accelerate Diagnostics, Inc. | Rapid determination of microbial growth and antimicrobial susceptibility |
| US10233483B2 (en) * | 2013-07-03 | 2019-03-19 | Qvella Corporation | Methods of targeted antibiotic susceptibility testing |
| EP2821499B1 (en) | 2013-07-04 | 2017-02-15 | ABM Technologies, LLC | Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics |
| JP2016540237A (ja) | 2013-12-06 | 2016-12-22 | バクテリオスキャン エルティーディー | 自由表面を有する液体の光学測定 |
| CN106062531B (zh) * | 2013-12-06 | 2019-03-08 | 百克特瑞欧扫描有限责任公司 | 用于对液体样品内粒子的特性进行光学测量的试管组件 |
| US10233481B2 (en) | 2014-12-05 | 2019-03-19 | Bacterioscan Ltd | Multi-sample laser-scatter measurement instrument with incubation feature and systems for using the same |
| US20160161404A1 (en) | 2014-12-05 | 2016-06-09 | Bacterioscan Ltd | System Using Laser-Scatter Measurement Instrument For Organism Identification And Related Network |
| US10065184B2 (en) | 2014-12-30 | 2018-09-04 | Bacterioscan Ltd. | Pipette having integrated filtration assembly |
| ES2710679T3 (es) * | 2015-01-21 | 2019-04-26 | Abm Tech Llc | Procedimiento para la determinación rápida de la susceptibilidad bacteriana a los antibióticos que inhiben la síntesis de las proteínas |
| CN107209115A (zh) | 2015-01-26 | 2017-09-26 | 百克特瑞欧扫描有限责任公司 | 具有转盘式流体样品装置的激光散射测量仪器 |
| KR20170132856A (ko) | 2015-03-30 | 2017-12-04 | 액셀러레이트 다이어그노스틱스, 아이엔씨. | 신속한 미생물 동정 및 항균제 감수성 시험을 위한 기기 및 시스템 |
| US10253355B2 (en) | 2015-03-30 | 2019-04-09 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
| MX2020000265A (es) | 2017-07-07 | 2020-07-22 | Epicentrx Inc | Composiciones para la administración parenteral de agentes terapéuticos. |
| US11099121B2 (en) | 2019-02-05 | 2021-08-24 | BacterioScan Inc. | Cuvette device for determining antibacterial susceptibility |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3933592A (en) * | 1965-02-17 | 1976-01-20 | Hazleton Laboratories, Incorporated | Method of detecting living microorganisms |
| JPH04370100A (ja) * | 1991-06-19 | 1992-12-22 | Mercian Corp | 微生物の薬剤感受性試験法 |
| GB9220027D0 (en) * | 1992-09-22 | 1992-11-04 | Mini Agriculture & Fisheries | Method and kits for detection of bacteria |
| US5648232A (en) * | 1993-01-21 | 1997-07-15 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Microbiological best method and reagents |
| GB9301118D0 (en) * | 1993-01-21 | 1993-03-10 | Secr Defence | Enzyme linked assays |
| JP2930725B2 (ja) * | 1993-07-12 | 1999-08-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | 不溶性分散相流体コンディショニング剤の改善された沈着性を有する高起泡性コンディショニングシャンプー |
| JP3856467B2 (ja) * | 1994-07-13 | 2006-12-13 | イギリス国 | 微生物学的試験方法および試薬 |
| GB9414096D0 (en) * | 1994-07-13 | 1994-08-31 | Secr Defence | Labelled capture assay |
-
1999
- 1999-01-12 US US09/600,398 patent/US6861230B1/en not_active Expired - Fee Related
- 1999-01-12 ES ES99901020T patent/ES2262308T3/es not_active Expired - Lifetime
- 1999-01-12 BR BR9907161-4A patent/BR9907161A/pt not_active Application Discontinuation
- 1999-01-12 WO PCT/GB1999/000089 patent/WO1999037799A1/en not_active Ceased
- 1999-01-12 DK DK99901020T patent/DK1049798T3/da active
- 1999-01-12 EP EP99901020A patent/EP1049798B1/en not_active Expired - Lifetime
- 1999-01-12 JP JP2000528706A patent/JP2002500892A/ja not_active Ceased
- 1999-01-12 NZ NZ505847A patent/NZ505847A/xx not_active IP Right Cessation
- 1999-01-12 AU AU20653/99A patent/AU751388C/en not_active Ceased
- 1999-01-12 AT AT99901020T patent/ATE330025T1/de active
- 1999-01-12 CA CA2318367A patent/CA2318367C/en not_active Expired - Fee Related
- 1999-01-12 CN CNB998042692A patent/CN1152963C/zh not_active Expired - Fee Related
- 1999-01-12 HU HU0101276A patent/HUP0101276A3/hu unknown
- 1999-01-12 DE DE69931892T patent/DE69931892T2/de not_active Expired - Lifetime
- 1999-01-12 GB GB0017298A patent/GB2348702B/en not_active Expired - Fee Related
-
2000
- 2000-07-19 NO NO20003708A patent/NO20003708L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1049798B1 (en) | 2006-06-14 |
| EP1049798A1 (en) | 2000-11-08 |
| DE69931892T2 (de) | 2006-12-21 |
| DE69931892D1 (de) | 2006-07-27 |
| HUP0101276A3 (en) | 2006-03-28 |
| CN1294634A (zh) | 2001-05-09 |
| NZ505847A (en) | 2002-09-27 |
| ATE330025T1 (de) | 2006-07-15 |
| WO1999037799A1 (en) | 1999-07-29 |
| AU751388B2 (en) | 2002-08-15 |
| AU2065399A (en) | 1999-08-09 |
| CA2318367C (en) | 2011-04-26 |
| DK1049798T3 (da) | 2006-10-09 |
| GB0017298D0 (en) | 2000-08-30 |
| AU751388C (en) | 2004-01-15 |
| JP2002500892A (ja) | 2002-01-15 |
| GB2348702A8 (en) | 2001-02-08 |
| NO20003708D0 (no) | 2000-07-19 |
| HUP0101276A2 (hu) | 2001-08-28 |
| GB2348702B (en) | 2003-04-02 |
| NO20003708L (no) | 2000-09-21 |
| CN1152963C (zh) | 2004-06-09 |
| BR9907161A (pt) | 2000-10-24 |
| CA2318367A1 (en) | 1999-07-29 |
| US6861230B1 (en) | 2005-03-01 |
| GB2348702A (en) | 2000-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2262308T3 (es) | Ensayos de sensibilidad a antibioticos. | |
| Tanji et al. | Escherichia coli detection by GFP-labeled lysozyme-inactivated T4 bacteriophage | |
| CA2027536C (en) | Method for determination of e.coli in water | |
| JP2002500892A5 (enExample) | ||
| CA2639926A1 (en) | Method and apparatus for determining level of microorganisms using bacteriophage | |
| BRPI0517957B1 (pt) | método para enriquecer, composição e kit para detectar um microrganismo alvo em uma amostra | |
| Awais et al. | A recombinant bacteriophage‐based assay for the discriminative detection of culturable and viable but nonculturable Escherichia coli O157: H7 | |
| AU773714B2 (en) | Cell assay, method and reagents | |
| JP2003511021A (ja) | 微生物を検出するためのデバイスおよび方法 | |
| ES2553153T3 (es) | Detección inmunocromatográfica de Staphylococcus multirresistente y kit de diagnóstico | |
| JP4578478B2 (ja) | バクテリオファージを使用した微生物を検出するための装置および方法 | |
| Cowan | Interpretation of properdin levels determined by phage neutralization technique | |
| US8377678B2 (en) | Methodology for detection, enumeration, propagation and manipulation of bacteriophages | |
| US7244612B2 (en) | Template reporter bacteriophage platform and multiple bacterial detection assays based thereon | |
| Miyanaga et al. | Detection of Escherichia coli in the sewage influent by fluorescent labeled T4 phage | |
| US20110097702A1 (en) | Methods and compositions for in situ detection of microorganisms on a surface | |
| CA2512636C (en) | Assay methods and materials | |
| KR100592693B1 (ko) | 항생제 민감성 시험방법 및 시험 키트 | |
| ES2645455T3 (es) | Medio cromogénico para detección e identificación de enterococos resistentes a vancomicina y procedimiento asociado | |
| ES2376708T3 (es) | Procedimiento de detección y/o de cuantificación y/o de identificación in vitro de bacterias en un material biológico. | |
| CN116018518A (zh) | 用于检测耐甲氧西林金黄色葡萄球菌的组合物、方法和系统 | |
| Stanek et al. | Rapid coliphage detection assay | |
| WO1995014105A2 (en) | Antibiotic sensitivity profile | |
| WO1999019508A1 (es) | Metodo para determinar la susceptibilidad de microorganismos que contienen acidos micolicos | |
| Aliyu et al. | Effects of Plasmid Curing on Multi-Drug-Resistant Salmonella from Poultry Litter in Nasarawa Town, Nasarawa State, Nigeria |